Correlation Between Replimune and Gracell Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Replimune and Gracell Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Gracell Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Gracell Biotechnologies, you can compare the effects of market volatilities on Replimune and Gracell Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Gracell Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Gracell Biotechnologies.
Diversification Opportunities for Replimune and Gracell Biotechnologies
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Replimune and Gracell is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Gracell Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gracell Biotechnologies and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Gracell Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gracell Biotechnologies has no effect on the direction of Replimune i.e., Replimune and Gracell Biotechnologies go up and down completely randomly.
Pair Corralation between Replimune and Gracell Biotechnologies
If you would invest (100.00) in Gracell Biotechnologies on December 30, 2024 and sell it today you would earn a total of 100.00 from holding Gracell Biotechnologies or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Replimune Group vs. Gracell Biotechnologies
Performance |
Timeline |
Replimune Group |
Gracell Biotechnologies |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Replimune and Gracell Biotechnologies Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Replimune and Gracell Biotechnologies
The main advantage of trading using opposite Replimune and Gracell Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Gracell Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gracell Biotechnologies will offset losses from the drop in Gracell Biotechnologies' long position.Replimune vs. Nuvalent | Replimune vs. Ventyx Biosciences | Replimune vs. Ascendis Pharma AS | Replimune vs. United Therapeutics |
Gracell Biotechnologies vs. Monte Rosa Therapeutics | Gracell Biotechnologies vs. Design Therapeutics | Gracell Biotechnologies vs. Erasca Inc | Gracell Biotechnologies vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |